Retinal alterations in mild cognitive impairment and Alzheimer's disease: An optical coherence tomography study

Journal of Neurology

Volumn 261, Issue 8, 2014, Pages 1522-1530

  Ascaso, Francisco J ^a   Cruz, Nancy ^a   Modrego, Pedro J ^b   Lopez Anton, Raul ^c   Santabárbara, Javier ^d   Pascual, Luis F ^a   Lobo, Antonio ^c,d   Cristóbal, José A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Alzheimer disease; Coherence tomography; Mild cognitive impairment; Optical

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; HUMAN; MACULAR THICKNESS; MALE; MILD COGNITIVE IMPAIRMENT; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PRIORITY JOURNAL; RETINA NERVE CELL; RETINAL NERVE FIBER LAYER THICKNESS; MENTAL HEALTH; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PHYSIOLOGY; RETINA; RETINA MACULA LUTEA; STATISTICAL MODEL; VERY ELDERLY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FEMALE; HUMANS; LINEAR MODELS; MACULA LUTEA; MALE; MENTAL STATUS SCHEDULE; MILD COGNITIVE IMPAIRMENT; MULTIVARIATE ANALYSIS; NERVE FIBERS; NEUROPSYCHOLOGICAL TESTS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84906096836     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-014-7374-z     Document Type: Article

References (53)

1. Prince M, Brice R, Ferry R. World Alzheimer report 201 Illinois: Alzheimer Disease Intenational, 201 Available at: http: www.alz.co.uk/ worldreport2011, Accessed 11 March 2014
2. Morris JM, Nagy Z (2004) Alzheimer's disease in the neuropathology of dementia. Cambridge University Press, UK, pp 161-206
3. Hinton DR, Sadun AA, Blanks JC, Miller CA (1986) Optic-nerve degeneration in Alzheimer's disease. N Engl J Med 315:485-487
4. Hof PR, Vogt BA, Bouras C, Morrison JH (1997) Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways. Vision Res 37:3609-3625
5. Blanks JC, Torigoe Y, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 17:377-384
6. Trick GL, Trick LR, Morris P, Wolf M (1995) Visual field loss in senile dementia of the Alzheimer's type. Neurology 45:68-74
7. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56:303-308
8. Levey A, Lah J, Goldstein F, Steenland K, Bliwise D (2006) Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease. Clin Ther 28:991-1001
9. Werner P, Korzcyn AD (2008) Mild cognitive impairment: conceptual, assessment, ethical, and social issues. Clin Interv Aging 3:413-420
10. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment - beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256:240-246
11. Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr (2009) Mild cognitive impairment: ten years later. Arch Neurol 66:1447-1455
12. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST (2001) Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56:1133-1142
13. Morris JC, Cummings J (2005) Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. J Alzheimers Dis 7:235-239
14. Makersbery WR, Schmitt FA, Kryscio RJ, Davis DG, Smith CD, Wekstein DR (2006) Neuropathologic substrate of mild cognitive impairment. Arch Neurol 63:38-46
15. Ikram MK, Cheung CY, Wong TY, Chen CP (2012) Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 83:917-922
16. Jaffe G-J, Caprioli J (2004) Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol 137:156-169
17. Hassenstein A, Spital G, Scholz F, Henschel A, Richard G, Pauleikhoff D (2009) Optical coherence tomography for macula diagnostics. Review of methods and standardized application concentrating on diagnostic and therapy control of age-related macula degeneration. Ophthalmologe 106:116-126
18. Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, Calabresi PA, Kerr DA (2009) Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73:302-308
19. Hajee M-E, March W-F, Lazzaro D-R et al (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127:737-741
20. Ascaso FJ, Cabezón L, Quintanilla MA, Gutiérrez-Galve L, López-Antón R, Cristóbal JA, Lobo A (2010) Retinal nerve fiber layer thickness mesured by optical coherence tomography in patients with schizophrenia: a short report. Eur J Psychiatry 24:227-235
21. Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci M-G, Pierelli F (2001) Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol 112:1860-1867
22. Iseri P-K, Altinas O, Tokay T, Yuksel N (2006) Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol 26:18-24
23. Berisha F, Feke G-T, Trempe C-L, McMeel J-W, Schepens C-L (2007) Retinal abnormalities in early Alzheimeŕs disease. Invest Ophthalmol Vis Sci 48:2285-2289
24. Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J (2007) Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 420:97-99
25. Yu JC, Feng IF, Xiang Y, Huanq JH, Savini G, Parisi V, Yang WJ, Fu Xa (2014) Retinal fiber nerve layer thickness changes in Parkinson disease: a meta-analysis. PLoS One 9:e85718
26. Moreno-Ramos T, Benito-León J, Villarejo A, Bermejo-Pareja F (2013) Retinal nerve fiber layer thinning in dementia associated with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease. J Alzheimers Dis 34:659-664
27. Blanks JC, Schmidt SY, Torigoe Y, Porrello KV, Hinton DR, Blanks RH (1996) Retinal pathology in Alzheimer's disease II. Regional neuron loss and glial changes in GCL. Neurobiol Aging 17:385-395
28. Lamirel C, Newman N, Biousse V (2009) The use of optical coherence tomography in Neurology. Rev Neurol Dis 6(4):e105-e120
29. Sakata L-M, Deleon-Ortega J, Sakata V, Girkin C-A (2009) Optical coherence tomography of the retina and optic nerve- a review. Clin Exp Ophthalmol 37:90-99
30. Streit WJ, Xue QS, Braak H, Del Tredici K (2014) Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain. Glia 62(1):96-105
31. Lobo A, Saz P, Marcos G et al (1999) Revalidation and standardization of the cognition mini-exam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population. Med Clin (Barc) 112:767-774
32. Katz S, Ford AB, Moskowitz RW et al (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 185:914-919
33. Alvarez M, De Alaiz AT, Brun E, Cabañeros JJ, Calzon M, Cosio I (1992) Capacidad funcional de pacientes mayores de 65 años, según el índice de Katz. Fiabilidad del método. Aten Primaria 10:812-816
34. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179-186
35. Tárraga LL (1995) Evaluación del deterioro cognitivo y functional de la demencia. Escalas de mayor interés en la Atención Primaria. In: Boada M, Tárraga LL (eds) El médico ante la demencia y su entorno, Módulo 1. Bayer S.A, Barcelona, pp 37-50
36. Pinheiro JC, Bates DM (2009) Mixed-effects models in S and S-PLUS, 2nd edn. Springer, New York
37. Blennow K, Hampel H (2003) CSF markers for incipient Alzheimer's disease. Lancet Neurol 2:605-613
38. Galasko D (2005) Biomarkers for Alzheimer's diseased clinical needs and application. J Alzheimers Dis 8:339-346
39. He XF, Liu YT, Peng C, Zhang F, Zhuang S, Zhang JS (2012) Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer's disease: a meta-analysis. Int J Ophthalmol 5:401-405
40. Frohman E-M, Fujimoto J-G, Frohman T-C et al (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4:664-675
41. Deng YL, Chen Y, Xie LQ, Wang G, Xu Wei, Tang YD, Wang Y, Chen SD (2009) Morphological change of retina in mild Alzheimer's disease. 8: 397-400
42. Chi Y, Wang YH, Yang L (2010) The investigation of retinal nerve fiber loss in Alzheimer's disease. 46: 134-139
43. Kesler A, Vakhapova V, Korczyn AD, Naftaliev E, Neudorfer M (2011) Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin Neurol Neurosurg 113:523-526
44. Kirbas S, Turkyilmaz K, Anlar O, Tufekci A, Durmus M (2013) Retinal nerve fiber layer thickness in patients with Alzheimer disease. J Neuroophthalmol 33:58-61
45. Schmidtke K, Hermeneit S (2008) High rate of conversion to Alzheimeŕs disease in a cohort of amnestic MCI patients. Int Psychogeriatr 20:96-108
46. Gramer E, Dirmeyer M (1998) Optical coherence tomography (OCT) to measure nerve fiber layer thickness in normal eyes. Invest Ophthalmol Vis Sci 39(4):S933 (abstract)
47. Heneka MT, Rodriguez JJ, Verkhratsky A (2010) Neuroglia in neurodegeneration. Brain Res Rev 63:189-211
48. Verkhratsky A, Olabarria M, Noristani HN, Yeh CY, Rodriguez JJ (2010) Astrocytes in Alzheimer's disease. Neurotherapeutics 7:399-412
49. Reichenbach A, Wurm A, Pannicke T, Iandiev I, Wiedemann P, Bringmann A (2007) Müller cells as players in retinal degeneration and edema. Graefe's Arch Clin Exp Ophthalmol 245:627-636
50. Bringmann A, Iandiev I, Pannicke T et al (2009) Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 28:423-451
51. Bringmann A, Wiedemann P (2011) Müller glial cells in retinal disease. Ophthalmologica 227:1-19
52. Fujino Y, Delucia MW, Davies P, Dickson DW (2004) Ballooned neurones in the limbic lobe are associated with Alzheimer type pathology and lack diagnostic specificity. Neuropathol Appl Neurobiol 30:676-682
53. Parisi V (2003) Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer's disease. Semin Ophthalmol 18:50-57